(EFXT) Enerflex - Overview
Stock: Compression, Processing, Cryogenic, Water Treatment, After-Market
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.28% |
| Yield on Cost 5y | 1.98% |
| Yield CAGR 5y | 12.37% |
| Payout Consistency | 90.2% |
| Payout Ratio | 7.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 53.8% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.65 |
| Alpha | 69.58 |
| Character TTM | |
|---|---|
| Beta | 1.280 |
| Beta Downside | 2.116 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.26% |
| CAGR/Max DD | 0.82 |
Description: EFXT Enerflex January 20, 2026
Enerflex Ltd. (NYSE:EFXT) is a Calgary-based provider of integrated energy-infrastructure and transition solutions across North America, Latin America, and the Eastern Hemisphere. Its product suite covers compression, processing, cryogenic, and treated-water systems, and it offers end-to-end services-from front-end engineering and design through construction, commissioning, and long-term aftermarket support such as parts distribution, O&M programs, and warranty agreements. The firm also supplies modular natural-gas handling and low-carbon assets, including CCUS (carbon capture, utilization, and storage) equipment, water-treatment modules, and electric-power generation packages.
Key operating metrics (FY 2023, disclosed in the latest 10-K) show revenue of $1.23 billion, an adjusted EBITDA margin of ≈ 15 %, and a free-cash-flow conversion of roughly 0.8 × EBITDA, reflecting a capital-intensive business model that relies on steady contract backlogs. The company’s performance is tightly linked to natural-gas demand growth (≈ 2-3 % YoY globally) and to capital-expenditure cycles in the mid-stream sector, which have been buoyed by rising LNG export projects and increasing emphasis on low-carbon processing solutions. A material risk is the exposure to commodity-price volatility and to potential slowdown in upstream drilling activity, which could compress new contract pipelines.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of Enerflex’s cash-flow dynamics and valuation levers, helping you assess whether the current market price reflects its long-term growth potential.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 189.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -5.43 > 1.0 |
| NWC/Revenue: 8.62% < 20% (prev 5.43%; Δ 3.19% < -1%) |
| CFO/TA 0.07 > 3% & CFO 279.0m > Net Income 189.3m |
| Net Debt (914.2m) to EBITDA (541.3m): 1.69 < 3 |
| Current Ratio: 1.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.4m) vs 12m ago -1.44% < -2% |
| Gross Margin: 23.13% > 18% (prev 0.20%; Δ 2293 % > 0.5%) |
| Asset Turnover: 102.0% > 50% (prev 112.0%; Δ -9.95% > 0%) |
| Interest Coverage Ratio: 4.17 > 6 (EBITDA TTM 541.3m / Interest Expense TTM 87.2m) |
Altman Z'' 1.73
| A: 0.08 (Total Current Assets 1.57b - Total Current Liabilities 1.26b) / Total Assets 3.97b |
| B: 0.07 (Retained Earnings 265.8m / Total Assets 3.97b) |
| C: 0.11 (EBIT TTM 363.7m / Avg Total Assets 3.45b) |
| D: 0.29 (Book Value of Equity 683.2m / Total Liabilities 2.37b) |
| Altman-Z'' Score: 1.73 = BBB |
Beneish M -2.87
| DSRI: 1.33 (Receivables 944.8m/660.0m, Revenue 3.52b/3.28b) |
| GMI: 0.86 (GM 23.13% / 19.90%) |
| AQI: 0.97 (AQ_t 0.31 / AQ_t-1 0.32) |
| SGI: 1.07 (Revenue 3.52b / 3.28b) |
| TATA: -0.02 (NI 189.3m - CFO 279.0m) / TA 3.97b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of EFXT shares?
Over the past week, the price has changed by -2.89%, over one month by +19.83%, over three months by +33.66% and over the past year by +93.10%.
Is EFXT a buy, sell or hold?
- StrongBuy: 4
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EFXT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.1 | -15.1% |
| Analysts Target Price | 15.1 | -15.1% |
| ValueRay Target Price | 23.4 | 31.2% |
EFXT Fundamental Data Overview February 07, 2026
P/E Forward = 16.6667
P/S = 0.824
P/B = 1.8318
Revenue TTM = 3.52b USD
EBIT TTM = 363.7m USD
EBITDA TTM = 541.3m USD
Long Term Debt = 648.0m USD (from longTermDebt, last quarter)
Short Term Debt = 30.6m USD (from shortTermDebt, last quarter)
Debt = 1.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 914.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.49b USD (1.58b + Debt 1.00b - CCE 89.1m)
Interest Coverage Ratio = 4.17 (Ebit TTM 363.7m / Interest Expense TTM 87.2m)
EV/FCF = 11.38x (Enterprise Value 2.49b / FCF TTM 219.0m)
FCF Yield = 8.79% (FCF TTM 219.0m / Enterprise Value 2.49b)
FCF Margin = 6.22% (FCF TTM 219.0m / Revenue TTM 3.52b)
Net Margin = 5.38% (Net Income TTM 189.3m / Revenue TTM 3.52b)
Gross Margin = 23.13% ((Revenue TTM 3.52b - Cost of Revenue TTM 2.71b) / Revenue TTM)
Gross Margin QoQ = 22.14% (prev 22.60%)
Tobins Q-Ratio = 0.63 (Enterprise Value 2.49b / Total Assets 3.97b)
Interest Expense / Debt = 1.99% (Interest Expense 20.0m / Debt 1.00b)
Taxrate = 40.32% (34.8m / 86.3m)
NOPAT = 217.0m (EBIT 363.7m * (1 - 40.32%))
Current Ratio = 1.24 (Total Current Assets 1.57b / Total Current Liabilities 1.26b)
Debt / Equity = 0.62 (Debt 1.00b / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = 1.69 (Net Debt 914.2m / EBITDA 541.3m)
Debt / FCF = 4.17 (Net Debt 914.2m / FCF TTM 219.0m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.49% (Net Income 189.3m / Total Assets 3.97b)
RoE = 15.59% (Net Income TTM 189.3m / Total Stockholder Equity 1.21b)
RoCE = 19.53% (EBIT 363.7m / Capital Employed (Equity 1.21b + L.T.Debt 648.0m))
RoIC = 12.26% (NOPAT 217.0m / Invested Capital 1.77b)
WACC = 6.96% (E(1.58b)/V(2.58b) * Re(10.63%) + D(1.00b)/V(2.58b) * Rd(1.99%) * (1-Tc(0.40)))
Discount Rate = 10.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.64%
[DCF Debug] Terminal Value 75.22% ; FCFF base≈259.6m ; Y1≈170.4m ; Y5≈77.7m
Fair Price DCF = 7.85 (EV 1.87b - Net Debt 914.2m = Equity 956.1m / Shares 121.8m; r=6.96% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 47.49 | EPS CAGR: 0.11% | SUE: -0.47 | # QB: 0
Revenue Correlation: 85.30 | Revenue CAGR: 38.20% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.39 | Chg30d=+0.039 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=+0.196 | Revisions Net=+1 | Growth EPS=+42.7% | Growth Revenue=-1.8%